C07D 277/06
With carbon atoms having three bonds to hetero atoms with at the
Official title: with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D277/06 (With carbon atoms having three bonds to hetero atoms with at the) appears on 339 US grants and 183 published applications in this corpus.
Search patents in C07D- Granted patents
- 339
- Published applications
- 183
- Assignees
- 183
- Inventors
- 908
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 16 | 0 |
| 1979 | 6 | 0 |
| 1980 | 14 | 0 |
| 1981 | 8 | 0 |
| 1982 | 8 | 0 |
| 1983 | 9 | 0 |
| 1984 | 14 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 10 | 0 |
| 1988 | 8 | 0 |
| 1989 | 10 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 11 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 5 |
| 2002 | 6 | 9 |
| 2003 | 8 | 13 |
| 2004 | 8 | 21 |
| 2005 | 7 | 19 |
| 2006 | 10 | 7 |
| 2007 | 9 | 9 |
| 2008 | 7 | 6 |
| 2009 | 2 | 9 |
| 2010 | 8 | 9 |
| 2011 | 3 | 6 |
| 2012 | 4 | 6 |
| 2013 | 2 | 5 |
| 2014 | 7 | 9 |
| 2015 | 6 | 7 |
| 2016 | 4 | 4 |
| 2017 | 8 | 6 |
| 2018 | 9 | 6 |
| 2019 | 4 | 6 |
| 2020 | 6 | 6 |
| 2021 | 5 | 4 |
| 2022 | 2 | 5 |
| 2023 | 1 | 4 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for gamma-glutamyl cycle modulation21 Jul 2026US 12,686,667 B2Cancer Research Technologies Limited
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Inhibitors of integrin alpha 2 beta 1 and methods of use7 Mar 2023US 11,597,727 B2The Regents of the University of California
- Methods for identifying and modulating co-occurant cellular phenotypes30 Aug 2022US 11,427,861 B2Massachusetts Institute of Technology
- EP300/CREBBP inhibitor15 Mar 2022US 11,274,100 B2Daiichi Sankyo Company, Limited
- Pharmaceutical for the inhibition of cellular proton pumps30 Oct 2025US 2025/0333389 A1
- Crystalline form of leucogen and method for preparation thereof and use thereof5 Jun 2025US 2025/0179037 A1Jiangsu Jibeier Pharmaceutical Co. Ltd.
- N-heterocyclic compounds used as nitrification inhibitor28 Dec 2023US 2023/0416168 A1Eurochem Antwerpen
- Broad spectrum anti-cancer compounds12 Oct 2023US 2023/0322715 A1The Regents of the University of California
- Methods for identifying and modulating co-occurant cellular phenotypes15 Jun 2023US 2023/0183786 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Amino acid derivatives100US 5,157,041 AHoffmann-La Roche Inc. · 1992
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996
- Arylsufonamido-substituted hydroxamic acids78US 5,506,242 ACiba-Geigy Corporation · 1996
- 3-phenyl-pyrrolidine-2,4-dione derivatives having pesticidal activity64US 5,116,836 ABayer Aktiengesellschaft · 1992